CHA2DS2-VASc Score Calculator

Enter clinical risk factors to calculate the CHA2DS2-VASc score and estimated annual ischemic stroke risk in non-valvular atrial fibrillation.

The CHA2DS2-VASc score sums points for congestive heart failure (1), hypertension (1), age 65–74 (1) or ≥75 (2), diabetes (1), prior stroke/TIA/thromboembolism (2), vascular disease (1), and female sex (1). For a 72-year-old woman with hypertension, the score is 3 (age 1 + female 1 + hypertension 1), corresponding to an untreated annual ischemic stroke risk of about 3.2%.

Free, runs in your browser. Nothing you enter is uploaded.

How to use it

  1. Select or enter the patient's age group.
  2. Check all present risk factors: heart failure, hypertension, diabetes, stroke history, vascular disease, and sex.
  3. Review the calculated CHA2DS2-VASc score and estimated annual stroke risk.
  4. Read the anticoagulation recommendation based on current major guidelines.

What you enter

What you get

Formula

C heart failure 1 + H hypertension 1 + A₂ age ≥75 2 + D diabetes 1 + S₂ stroke/TIA/embolism 2 + V vascular disease 1 + A age 65–74 1 + Sc female 1 (CHA2DS2-VA omits sex)

The CHA2DS2-VASc score estimates the annual risk of ischemic stroke in patients with non-valvular atrial fibrillation. It assigns points for specific clinical risk factors: congestive heart failure (1 point), hypertension (1 point), age 75 years or older (2 points), diabetes mellitus (1 point), prior stroke, transient ischemic attack, or thromboembolism (2 points), vascular disease such as myocardial infarction, peripheral artery disease, or aortic plaque (1 point), age 65 to 74 years (1 point), and female sex (1 point). The maximum possible score is 9.

The total score is linked to an untreated annual ischemic stroke rate, derived from the 2012 Swedish Atrial Fibrillation cohort study by Friberg and colleagues. The rates are: score 0, 0.2%; 1, 0.6%; 2, 2.2%; 3, 3.2%; 4, 4.8%; 5, 7.2%; 6, 9.7%; 7, 11.2%; 8, 10.8%; and 9, 12.2%. These percentages represent the expected proportion of patients who would experience an ischemic stroke over one year without anticoagulation.

The score guides anticoagulation decisions. The 2023 ACC/AHA/ACCP/HRS guideline recommends oral anticoagulation for men with a score of 2 or higher and for women with a score of 3 or higher. Anticoagulation is considered reasonable for men with a score of 1 and women with a score of 2. The 2024 ESC guideline uses the CHA2DS2-VA score, which omits the sex category. It recommends anticoagulation at a score of 2 or higher and considers it at a score of 1.

The CHA2DS2-VASc score is not used for patients with valvular atrial fibrillation, defined as atrial fibrillation with moderate-to-severe mitral stenosis or a mechanical heart valve. Bleeding risk is assessed separately, typically with the HAS-BLED score, and an elevated bleeding risk alone is not a reason to withhold anticoagulation.

The original CHADS2 score, published by Gage in 2001, was a simpler predecessor. CHA2DS2-VASc refined risk stratification by adding vascular disease, age 65–74, and female sex, improving identification of truly low-risk patients.

Worked example

Input: 72-year-old woman with hypertension

Result: CHA2DS2-VASc 3; CHA2DS2-VA 2

Oral anticoagulation recommended; untreated stroke risk about 3.2% a year.

Questions

What is the CHA2DS2-VASc score used for?

The CHA2DS2-VASc score estimates the annual risk of ischemic stroke in patients with non-valvular atrial fibrillation. It helps clinicians decide whether to start oral anticoagulation. The score is not used for patients with moderate-to-severe mitral stenosis or a mechanical heart valve.

How do you calculate a CHA2DS2-VASc score?

Add points for each risk factor: congestive heart failure (1), hypertension (1), age 75 or older (2), diabetes (1), prior stroke/TIA/thromboembolism (2), vascular disease (1), age 65–74 (1), and female sex (1). The total ranges from 0 to 9.

What does a CHA2DS2-VASc score of 2 mean?

A score of 2 corresponds to an untreated annual ischemic stroke risk of about 2.2%. For men, a score of 2 is the threshold for a formal anticoagulation recommendation under the 2023 ACC/AHA guideline. For women, a score of 2 is considered reasonable for anticoagulation.

When is anticoagulation recommended based on CHA2DS2-VASc?

The 2023 ACC/AHA guideline recommends anticoagulation for men with a score of 2 or higher and for women with a score of 3 or higher. The 2024 ESC guideline uses CHA2DS2-VA (which drops sex) and recommends anticoagulation at a score of 2 or higher.

What is the difference between CHADS2 and CHA2DS2-VASc?

CHADS2 was the original score from 2001, using heart failure, hypertension, age 75 or older, diabetes, and stroke (2 points). CHA2DS2-VASc added vascular disease, age 65–74, and female sex to better identify truly low-risk patients who may not need anticoagulation.

Does a high CHA2DS2-VASc score mean I should not take anticoagulants if I have a bleeding risk?

No. Bleeding risk is assessed separately, often with the HAS-BLED score. An elevated bleeding risk alone is not a reason to withhold anticoagulation. The decision balances stroke risk against bleeding risk, and most patients with a high CHA2DS2-VASc score still benefit from anticoagulation.

Limitations

References

More Health & Wellness

All free tools · By Dr. Zubair Khalid, DVM, MS, PhD.